Novartis India Q1 net profit jumps over 5-fold to Rs 4.39 cr on price cuts

The company had posted a net profit of Rs 79 lakh in the corresponding period of previous fiscal

Topics
Novartis India | Q1 results

Press Trust of India  |  New Delhi 

Novartis India MD Milan Paleja to step down with effect from May 31
Total expenses of the company were at Rs 93 crore in the quarter under review as against Rs 118.89 crore in April-June quarter

Drug firm on Thursday reported over five-fold jump in net profit at Rs 4.39 crore for the quarter ended June 30, 2020, mainly on account of reduction in expenses.

The company had posted a net profit of Rs 79 lakh in the corresponding period of previous fiscal, said in a filing to the BSE.

Revenue from operations stood at Rs 92.46 crore in the quarter under consideration as against Rs 109.31 crore in the same quarter a year ago, it added.

Total expenses of the company were at Rs 93 crore in the quarter under review as against Rs 118.89 crore in April-June quarter a year ago.

Shares of on Thursday closed 0.95 per cent lower at Rs 644.40 on the BSE.

Read our full coverage on Novartis India
First Published: Thu, August 06 2020. 20:54 IST